Skip to Main Content

Paper Details

Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131.
J Clin Oncol
77
2021
Author NameAffiliation
Ingrid A MayerVanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center
William F SymmansMD Anderson Cancer Center
Ben Ho ParkVanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center
Ben Ho ParkVanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center
Antonio C WolffJohns Hopkins University, Sidney Kimmel Cancer Center
  • 1 - 5

Datasets

Release 1.2